ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.40 +0.27 (+6.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Finished Goods (2024 - 2025)

Updated

ARS Pharmaceuticals' Finished Goods was $7.27 million in Q1 2025, up 39.5% from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Finished Goods (2024 - 2025) Analysis & Trends

At the end of FY2024, Finished Goods at ARS Pharmaceuticals came in at $5.21 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 ARS Pharmaceuticals 410.68 Mn 266.88 Mn 20.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 7.27 Mn
Dec 31, 2024 5.21 Mn
API Access

ARS Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=SPRY&period=max&api_key=YOUR_API_KEY